astrazeneca oral glp 1 Elecoglipron, an small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial In Potential $2B Deal, AstraZeneca
Pay in 4 interest-free payments of $7.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



























/assets/images/provider/photos/2554335.jpg)
